Live to 150? Jim Mel­lon and the crew at Ju­ve­nes­cence just raised $46M more to give it a try

With his 62nd birth­day loom­ing next month, the sci­ence of an­ti-ag­ing isn’t just an­oth­er throw of the dice for British in­vestor Jim Mel­lon.

“We could do with the tech­nol­o­gy our­selves,” he says on be­half of the ex­pe­ri­enced ex­ecs lead­ing Ju­ve­nes­cence, Mel­lon’s up­start biotech ven­ture. And he’s not just think­ing about an­oth­er good 40 or 50 years. In­stead, he and the Ju­ve­nes­cence team are talk­ing about mov­ing the goal posts of life to 150, crack­ing the bi­o­log­i­cal bar­ri­ers that have formed a brick wall at 120.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER